Overall, future research should focus on elucidating the mechanisms by which NEU1 regulates EV glycosylation, developing specific NEU1 inhibitors and exploring the potential of EV glycosylation as a biomarker for AD. This evidence concerns the gene NEU1 and Alzheimer disease.